TY  - JOUR
AU  - Auxiliadora Bajo, Maria
AU  - Rios Moreno, Francisco
AU  - Dolores Arenas, Maria
AU  - Deuesa Such, Ramon Jesus
AU  - Molina Higueras, Maria Jose
AU  - Delgado, Margarita
AU  - Molina, Pablo
AU  - Garcia Fernandez, Nuria
AU  - Martin Malo, Alejandro
AU  - Peiro-Jordan, Roser
AU  - Cannata-Andia, Jorge
AU  - Martin de Franciscorl, Angel Luis
PY  - 2021
DO  - 10.1016/j.nefro.2021.04.015
SN  - 0211-6995
UR  - http://hdl.handle.net/10668/22412
T2  - Nefrologia
AB  - Background and aims: In this study, we show the results of the subset of Spanish patients of the VERIFIE study, the first post-marketing study assessing the long-term safety and effectiveness of sucroferric oxyhydroxide (SFOH) in patients with...
LA  - es
PB  - Soc espanola nefrologia dr rafael matesanz
KW  - Dialysis
KW  - Sucroferric oxyhydroxide
KW  - Phosphate binder
KW  - Safety
KW  - Clinical practice
KW  - Chronic kidney-disease
KW  - Phosphate binder pa21
KW  - Hemodialysis-patients
KW  - Hyperphosphatemia
KW  - Efficacy
KW  - Bone
KW  - Dialisis
KW  - Oxihidroxido sucroferrico
KW  - Captor de fosforo
KW  - Seguridad
KW  - Practica clinica
KW  - Drug Combinations
KW  - Ferric Compounds
KW  - Humans
KW  - Phosphorus
KW  - Renal Dialysis
TI  - Seguridad y efectividad del oxihidroxido sucroferrico en pacientesespañoles en diálisis: subanalisis del estudio VERIFIE
T2  - Safety and effectiveness of sucroferric oxyhydroxide in Spanish dialysis patients: A sub-analysis of the VERIFIE study
TY  - research article
VL  - 42
ER  -